Beyond Histology: The MERIT of Molecular Phenotyping with HeartCare
Now available on-demand
Watch our interactive panel discussion featuring real-world patient case examples, including novel use of HeartCare, landmark data from SHORE, and innovative clinical scenarios.
From Signal to Action: Can AlloSure Lung Inform Earlier Intervention?
Now available on-demand
Watch our interactive case discussion with leaders in lung transplant, featuring innovative new data from ALAMO.
CareDx Abstracts Presented at ISHLT
See real-world evidence about CareDx solutions at ISHLT 2026 – view our abstract table.
CareDx featured in:
50+ abstracts total
16 oral presentations
95 centers' data
Gene Expression Profiling (GEP) and Donor-Derived Cell-Free DNA (dd-cfDNA) Levels Are Elevated Prior to Acute Rejection
Elevations in HeartCare (AlloMap Heart and AlloSure Heart) were observed months prior to acute cellular and antibody-mediated rejection.
Donor Derived cfDNA% Reference Change from Individualized Baseline (CIB) is Associated with Clinically Significant Loss of Spirometric-Function and Acute Lung Allograft Dysfunction Events After Lung Transplantation
Magnitude of change from personalized AlloSure Lung baseline was associated with increased risk of clinically significant lung function loss, with age-dependent differences noted in the analysis.
Stay connected
Sign up for conference updates from CareDx